Markets › India › NSE › AKUMS

Akums Drugs and Pharmaceuticals Ltd

NSE:AKUMSHealthcareNSE:NIFTY_MICROCAP250NSE:NIFTY_TOTAL_MKT

₹709.55−2.99%At closeAt close · Mon 19 Oct · ≈ AED 27.41 · Market cap $1.21B · Next earnings Thu 12 Nov

INR billions	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025	YoY
Net income	—	(1.9)	1.5	(0.5)	3.5	2.6	−26.1%
Depreciation & amortization	0.7	0.9	1.1	1.3	1.5	1.5	+0.7%
Stock-based compensation	—	0.0	0.0	0.0	0.0	0.0	—
Change in working capital	(1.4)	(3.5)	(0.3)	0.5	0.3	7.2	+2057.8%
Operating cash flow	1.3	0.3	1.8	5.0	4.7	12.1	+160.3%
Capital expenditure	(0.8)	(2.6)	(3.3)	(3.1)	(2.7)	(2.3)	+15.3%
Acquisitions	—	(0.1)	(0.0)	0.0	0.0	0.1	—
Investing cash flow	—	(2.3)	(3.0)	(3.3)	(5.5)	(9.7)	−76.9%
Dividends paid	0.0	0.0	0.0	0.0	0.0	0.0	—
Share buybacks	—	0.0	0.0	0.0	0.0	0.0	—
Debt issued / repaid	—	2.6	1.8	(0.5)	(4.8)	0.6	+112.4%
Financing cash flow	—	2.4	1.2	(1.1)	0.7	0.4	−40.9%
Free cash flow	0.5	(2.3)	(1.5)	1.9	1.9	9.8	+408.2%
Net change in cash	—	0.3	(0.0)	0.6	(0.1)	15.8	+16120.0%